Ads

 

Ads

 

Ads

 

World Top 1,000 Companies as of January 2024

World Top 1,000 Companies by Market Cap as of January 2024 from Value.Today

World Top 1,000 Companies by Market Cap as of Jan-05-2024. World Biggest 1,000 Companies by Market Cap as of Jan-05-2024. In 2024 also Apple retained World 1st Rank by Market Cap. Second position is occupied by Microsoft. USA companies got First and second rank positions. Third position is occupied by Saudi Aramco from Saudi Arabia.

World Top 1,000 Companies market cap or net worth as of Jan-05-2024 was 77.29 Trillion USD. Both listed and unlisted companies data is considered.

CIMC Enric Holdings

World Rank (Jan-05-2024)
6,037
Market Cap (Jan-05-2024)
1.813 Billion USD
World Rank (Jul-30-2023)
5,840
Market Cap (Jul-30-2023)
1.950 Billion USD
World Rank (Dec-25-2022)
5,495
Market Cap (Dec-25-2022)
1.975 Billion USD
World Rank (Jan-07-2022)
5,021
Market Cap (Jan-07-2022)
2.86 Billion USD
Headquarters Country

Assura

World Rank (Jan-05-2024)
6,038
Market Cap (Jan-05-2024)
1.813 Billion USD
World Rank (Jul-30-2023)
6,123
Market Cap (Jul-30-2023)
1.807 Billion USD
World Rank (Dec-25-2022)
5,577
Market Cap (Dec-25-2022)
1.923 Billion USD
World Rank (Jan-07-2022)
5,131
Market Cap (Jan-07-2022)
2.77 Billion USD
Annual Revenue in USD
160 Million USD
Annual Net Income in USD
183 Million USD
Annual Results for Period Ending
Mar-2022 ending year
Headquarters Country
Company Profile
Assura is a specialist Real Estate Investment Trust company working only on healthcare premises. The company quarterly revenue is 111.50 million EUR and 79 employees as on 2020. The headquarters is in UK.

Prokidney Corp.

World Rank (Jan-05-2024)
6,039
Market Cap (Jan-05-2024)
1.812 Billion USD
World Rank (Jul-30-2023)
4,581
Market Cap (Jul-30-2023)
2.807 Billion USD
World Rank (Dec-25-2022)
5,906
Market Cap (Dec-25-2022)
1.755 Billion USD
Headquarters Country
Company Profile

ProKidney is a late clinical-stage biotech company focused on the development of a pioneering cell therapy candidate that aims to transform the treatment landscape for Chronic Kidney Disease using a patient’s own cells.

The headquarters is in USA.

PT Perusahaan Gas Negara TBK

World Rank (Jan-05-2024)
6,040
Market Cap (Jan-05-2024)
1.810 Billion USD
World Rank (Jul-30-2023)
5,434
Market Cap (Jul-30-2023)
2.182 Billion USD
World Rank (Dec-25-2022)
4,392
Market Cap (Dec-25-2022)
2.734 Billion USD
World Rank (Jan-07-2022)
5,696
Market Cap (Jan-07-2022)
2.33 Billion USD
Headquarters Country
Company Profile
PT Perusahaan Gas Negara Tbk is a Natural Gas Distribution company. The company annual revenue is 3.848 billion USD, annual net income is 113 million USD, total assets is 7.373 billion USD and     3,119 employees as on 2019. The headquarters is in Indonesia.

PT Ciputra Development TBK

World Rank (Jan-05-2024)
6,041
Market Cap (Jan-05-2024)
1.810 Billion USD
World Rank (Jul-30-2023)
5,427
Market Cap (Jul-30-2023)
2.192 Billion USD
World Rank (Dec-25-2022)
7,879
Market Cap (Dec-25-2022)
1.111 Billion USD
World Rank (Jan-07-2022)
8,418
Market Cap (Jan-07-2022)
1.22 Billion USD
Annual Revenue in USD
657 Million USD
Annual Net Income in USD
117 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Headquarters Country
Company Profile
PT Ciputra Development Tbk is a real estate company that has developed more than 76 projects, ranging from residential, apartments, offices, shopping centers, hotels, hospitals, to golf courses, spread across 33 cities throughout Indonesia. The company annual revenue is 9,729,651 million IDR and annual net income is 1,735,329 million IDR for year ending December 2021. The headquarters is in Indonesia.

77 Bank

World Rank (Jan-05-2024)
6,042
Market Cap (Jan-05-2024)
1.810 Billion USD
World Rank (Jul-30-2023)
6,889
Market Cap (Jul-30-2023)
1.495 Billion USD
World Rank (Dec-25-2022)
7,617
Market Cap (Dec-25-2022)
1.177 Billion USD
World Rank (Jan-07-2022)
10,076
Market Cap (Jan-07-2022)
0.89 Billion USD
Annual Revenue in USD
818 Million USD
Annual Net Income in USD
162 Million USD
Annual Results for Period Ending
Mar-2022 ending year
Headquarters Country

Gubre Fabrikalari T.A.S

World Rank (Jan-05-2024)
6,043
Market Cap (Jan-05-2024)
1.809 Billion USD
World Rank (Jul-30-2023)
3,608
Market Cap (Jul-30-2023)
3.897 Billion USD
World Rank (Dec-25-2022)
2,802
Market Cap (Dec-25-2022)
4.841 Billion USD
World Rank (Jan-07-2022)
6,323
Market Cap (Jan-07-2022)
1.98 Billion USD
Annual Revenue in USD
593 Million USD
Annual Net Income in USD
29 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Headquarters Country
Company Profile
Gubre Fabrikalari TAS is a Production and Marketing of Chemical company. It is having 1,569 employees as on 2019. The headquarters is in Turkey.

Addsino

World Rank (Jan-05-2024)
6,044
Market Cap (Jan-05-2024)
1.809 Billion USD
World Rank (Jul-30-2023)
5,502
Market Cap (Jul-30-2023)
2.133 Billion USD
World Rank (Dec-25-2022)
5,156
Market Cap (Dec-25-2022)
2.176 Billion USD
World Rank (Jan-07-2022)
3,707
Market Cap (Jan-07-2022)
4.25 Billion USD
Annual Revenue in USD
603 Million USD
Annual Net Income in USD
94 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Headquarters Country

Amneal Pharmaceuticals

World Rank (Jan-05-2024)
6,045
Market Cap (Jan-05-2024)
1.809 Billion USD
World Rank (Jul-30-2023)
8,910
Market Cap (Jul-30-2023)
0.965 Billion USD
World Rank (Dec-25-2022)
15,083
Market Cap (Dec-25-2022)
0.333 Billion USD
World Rank (Jan-07-2022)
11,500
Market Cap (Jan-07-2022)
0.69 Billion USD
Annual Revenue in USD
2,212 Million USD
Annual Operating Income in USD
188 Million USD
Annual Net Income in USD
-129 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Headquarters Country
Company Profile
Amneal Pharmaceuticals is an Integrated Specialty Pharmaceutical company. It is powered by a robust U.S. generics business and a growing branded business and focused on delivering outcomes that meet important medical needs, make quality medicines more accessible and more affordable and provide solutions for tomorrows health challenges. The headquarters is in USA.

Inhibrx Inc.

World Rank (Jan-05-2024)
6,046
Market Cap (Jan-05-2024)
1.809 Billion USD
World Rank (Jul-30-2023)
7,998
World Rank (Dec-25-2022)
7,998
Market Cap (Dec-25-2022)
1.081 Billion USD
World Rank (Jan-07-2022)
8,138
Market Cap (Jan-07-2022)
1.29 Billion USD
Annual Revenue in USD
7,125 Million USD
Annual Net Income in USD
-81 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Headquarters Country
Company Profile
Inhibrx is a Clinical Stage Biotechnology company developed a diverse pipeline of therapeutic candidates specifically designed to leverage the power of core sdAb (single-domain antibody) platform and protein engineering expertise. The company annual revenue is 34.1 million USD and 80 employees as on 2020. The headquarters is in USA.

Share

Ads